Autotransfusion Devices and Consumables Market Overview
The Global Autotransfusion Devices and Consumables Market size was at US$ 815.20 million in 2025 and is expected to reach US$ 1,349.16 million by 2033, growing at a CAGR of 6.5% during the forecast period 2026-2033.
Autotransfusion devices are medical devices used to collect and reinfuse a patient's own blood during and after surgery, reducing the need for allogeneic (donor) blood transfusions. These devices are crucial in managing blood loss and minimising the risk of transfusion-related complications. Autotransfusion systems are used in various surgeries with high blood loss, such as cardiac, orthopaedic, trauma, vascular, obstetric, and transplant procedures. They consistently provide high-quality washed red blood cells with excellent heparin and protein removal.
Autotransfusion Devices and Consumables Market Scope
| Metrics | Details |
| CAGR | 6.5% |
| Market Size Available for Years | 2023-2033 |
| Estimation Forecast Period | 2026-2033 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product Type, Usage, Application, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report – Request for Sample
Autotransfusion Devices and Consumables Market Dynamics
Rise in the number of surgical procedures
These surgeries, characterized by substantial blood loss, benefit immensely from autotransfusion technology, which offers clinical and economic advantages by enhancing patient safety, reducing transfusion-related risks, and improving overall surgical outcomes. As these surgical procedures continue to rise globally, the reliance on and adoption of autotransfusion devices is expected to increase correspondingly.
For instance, according to the American Academy of Orthopaedic Surgeons (AAOS) and the Agency for Healthcare Research and Quality (AHRQ), an estimated 700,000 knee replacement and around 450,000 hip replacement procedures are performed in the U.S. each year. Besides, according to an article published by the University of Alabama in 2021, it was reported that 320,000 Coronary Artery Bypass Grafting procedures were performed in the U.S. in 2020. This, combined with the increasing awareness of intraoperative & post-operative blood salvage, is anticipated to offer substantial opportunity for the growth of the global market.
Rise in shift towards minimally invasive surgeries
The trend of patients shifting from invasive surgeries to minimally invasive ones is expected to increase due to factors like reduced hospital stays, cost, faster recovery, and superior patient comfort. Hence, this shift is expected to decrease the need for blood conservation or allogeneic transfer.
Autotransfusion Devices and Consumables Market Segmentation Analysis
The global autotransfusion devices and consumables market is segmented based on product type, usage, application, end-user and region.
The blood processing and collection devices from the product type segment accounted for approximately 41.3% of the autotransfusion devices and consumables market share
The blood processing and collection devices from the product type segment accounted for approximately 41.3%. Blood processing and collection devices play a crucial role in the autotransfusion devices market. These devices are essential components of autotransfusion systems, enabling the collection, processing, and reinfusion of a patient's own blood during surgical procedures. By utilizing autotransfusion devices, blood shed during surgery can be collected, processed, and filtered to remove impurities before being reinfused back into the patient, reducing the need for allogeneic (donor) blood transfusions.
Autotransfusion Devices and Consumables Market Geographical Share
North America is estimated to hold about 38.4% of the total market share throughout the forecast period.
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like mainly due to the presence of key players in the country, rising healthcare expenses, and the increasing number of surgeries. Moreover, FDA approvals, novel product launches and increasing awareness of autotransfusion devices due to the lack of allogeneic blood in the region are some of the factors increasing the autotransfusion devices market size during the forecast period.
For instance, in February 2024, ProCell Surgical received CE-marked approval for its Sponge Blood Recovery Unit, allowing it to enter the European Union market. The certification indicates that ProCell’s product complies with the EU’s Medical Devices Regulation (EU) 2017/745. The company’s patented technology modernises the process of surgical sponge-blood recovery, enhancing intraoperative autotransfusion (IAT) systems in hospitals.
Moreover, in March 2023, Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on the next-generation software for the Cell Saver Elite Autotransfusion System.
Autotransfusion Devices and Consumables Market Key Players
The major global players in the market include Medtronic Plc, LivaNova Plc, Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Zimmer Biomet Holdings Inc, Braile Biomédica, Redax, Beijing ZKSK Technology, Advancis Surgical among others.
Key Developments in the Autotransfusion Devices and Consumables Market
- April 2026: LivaNova updated its corporate product impact data, reporting that more than 5 million patients had been treated using the XTRA™ Autotransfusion System, with a 3% increase in patients treated, highlighting continued global adoption of advanced intraoperative blood-recovery technology.
- February 2026: Haemonetics continued expanding technical support and professional training for its Cell Saver® Elite®+ platform, scheduling multiple 2026 biomedical training programs covering maintenance and system support for the autotransfusion device ecosystem.
- January 2026: Medtronic released updated 2026 coding and reimbursement information supporting the autoLog IQ™ Autotransfusion System, reinforcing hospital adoption of intraoperative blood collection, processing, washing, and reinfusion technologies.
Why Choose DataM?
- Technological Innovations: Explores advancements in autotransfusion technologies, including intraoperative blood salvage systems, automated blood collection and processing platforms, centrifugal separation technologies, continuous and discontinuous autotransfusion systems, and closed-loop blood recovery solutions designed to support efficient collection, processing, washing, and reinfusion of a patient’s own blood during surgical and trauma procedures.
- Product Performance & Market Positioning: Evaluates autotransfusion devices and consumables based on critical parameters such as blood recovery efficiency, processing speed, red blood cell recovery, hematocrit levels, washing performance, ease of operation, automation, portability, and compatibility with surgical workflows, highlighting how manufacturers differentiate through clinical performance, reliability, and ease of use.
- Real-World Evidence: Highlights the use of autotransfusion devices and consumables across cardiac surgery, orthopedic surgery, trauma care, organ transplantation, vascular surgery, and other procedures associated with significant blood loss, demonstrating their role in supporting patient blood management and reducing dependence on allogeneic blood transfusion where clinically appropriate.
- Market Updates & Industry Changes: Tracks developments including product launches, technological improvements in blood salvage and processing systems, changes in patient blood management practices, evolving clinical guidelines, healthcare infrastructure investments, and regulatory developments influencing the adoption of autotransfusion technologies across major healthcare markets.
- Competitive Strategies: Analyzes how leading companies strengthen their market presence through product innovation, expansion of disposable and consumable portfolios, strategic collaborations, distribution partnerships, healthcare provider relationships, geographic expansion, and the development of systems designed to improve workflow efficiency in operating rooms and other clinical settings.
- Pricing & Market Access: Explains pricing variations based on device type, level of automation, processing capacity, technology features, disposable consumable requirements, and service agreements, along with market access through direct sales, medical device distributors, hospital procurement networks, and healthcare supply channels.
- Market Entry & Expansion: Identifies growth opportunities associated with increasing surgical procedure volumes, greater emphasis on patient blood management, demand for efficient blood conservation strategies, and expansion of advanced surgical and hospital infrastructure, while outlining approaches such as product differentiation, clinical evidence generation, strategic distribution partnerships, and expansion into emerging healthcare markets.
The global autotransfusion devices and consumables market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience
- Hospitals & Healthcare Systems
- Ambulatory Surgical Centers
- Cardiac & Cardiovascular Surgery Centers
- Orthopedic Surgery Centers
- Trauma & Emergency Care Facilities
- Medical Device Manufacturers
- Autotransfusion Device & Consumable Suppliers
- Blood Management Solution Providers
